Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-infectious Posterior Uveitis”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Large-scale testing (Phase 3)Ended earlyNCT01032915
What this trial is testing

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis

Who this might be right for
Non-infectious Uveitis
Novartis Pharmaceuticals 125
Large-scale testing (Phase 3)Looking for participantsNCT05486468
What this trial is testing

The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

Who this might be right for
UveitisUveitis, PosteriorUveitis, Anterior+1 more
Texas Retina Associates 30
Not applicableStudy completedNCT03339102
What this trial is testing

Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis Patients

Who this might be right for
Non-infectious Intermediate, Posterior and Panuveitis
AbbVie 158
Post-approval studies (Phase 4)UnknownNCT00720928
What this trial is testing

Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease

Who this might be right for
Ocular Behcet's Disease,Non-Infectious UveitisRefractory Uveitis
Asan Medical Center 15
Large-scale testing (Phase 3)Ended earlyNCT05070728
What this trial is testing

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert

Who this might be right for
UveitisUveitis, PosteriorUveitis, Intermediate
EyePoint Pharmaceuticals, Inc. 12
Testing effectiveness (Phase 2)WithdrawnNCT01280669
What this trial is testing

Intravitreal Sirolimus as Therapeutic Approach to Uveitis

Who this might be right for
UveitisIntermediate UveitisPosterior Uveitis+1 more
Stanford University
Large-scale testing (Phase 3)Ended earlyNCT02258854
What this trial is testing

An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data

Who this might be right for
Uveitis
XOMA (US) LLC 69
Not applicableActive Not RecruitingNCT07262437
What this trial is testing

Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles

Who this might be right for
Uveitis Posterior Non-InfectiousInflammation EyeUveitis+1 more
University of Milan 220
Testing effectiveness (Phase 2)UnknownNCT01717170
What this trial is testing

Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study

Who this might be right for
Intermediate UveitisPosterior UveitisPan-uveitis
University of Nebraska 36
Not applicableUnknownNCT04126850
What this trial is testing

Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis Disease

Who this might be right for
Autoimmune UveitisBehçet DiseaseVogt-Koyanagi-Harada Disease+5 more
Fakultas Kedokteran Universitas Indonesia 10
Large-scale testing (Phase 3)Ended earlyNCT01095250
What this trial is testing

Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

Who this might be right for
Uveitis
Novartis Pharmaceuticals 30
Early research (Phase 1)Study completedNCT00078689
What this trial is testing

Daclizumab and Sirolimus to Treat Uveitis

Who this might be right for
Uveitis
National Eye Institute (NEI) 6
Large-scale testing (Phase 3)Ended earlyNCT01684345
What this trial is testing

Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis

Who this might be right for
Uveitis
XOMA (US) LLC 200
Post-approval studies (Phase 4)Study completedNCT05414201
What this trial is testing

Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uveitis

Who this might be right for
Non-infectious Intermediate Posterior- or Pan-uveitis
AbbVie 87
Testing effectiveness (Phase 2)Study completedNCT00615693
What this trial is testing

Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis

Who this might be right for
UveitisPosterior UveitisPanuveitis
Novartis 13
Post-approval studies (Phase 4)UnknownNCT05322070
What this trial is testing

Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis

Who this might be right for
Uveitis, Posterior
Alimera Sciences 125
Large-scale testing (Phase 3)Study completedNCT00333814
What this trial is testing

The Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis

Who this might be right for
Intermediate UveitisPosterior Uveitis
Allergan 229
Testing effectiveness (Phase 2)Study completedNCT00685399
What this trial is testing

Safety and Efficacy of AIN457 in Noninfectious Uveitis

Who this might be right for
Non-infectious Uveitis
Novartis Pharmaceuticals 76
Large-scale testing (Phase 3)WithdrawnNCT01103024
What this trial is testing

Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

Who this might be right for
Uveitis
Novartis
Large-scale testing (Phase 3)Study completedNCT00404742
What this trial is testing

LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis

Who this might be right for
Uveitis, PosteriorUveitis, IntermediatePanuveitis
Lux Biosciences, Inc. 232
Next Page